Abstract | OBJECTIVE: DESIGN: A prospective cohort study. SETTING: Academic spine center. PARTICIPANTS: Patients (N = 100) undergoing a diagnostic injection followed by a therapeutic injection in the axial skeleton. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: Presence or absence of dysphonia and/or associated throat symptoms, as determined by completion of a predetermined 10-item questionnaire. This questionnaire was administered before participation in the study and at specific intervals after a diagnostic injection and, again, after a therapeutic spinal injection. RESULTS: There was a 12% incidence of transient dysphonia and/or associated throat symptoms in this study population after a therapeutic injection. CONCLUSIONS: Throat symptoms are a potential, albeit transient side effect, after an epidural space corticosteroid injection. The mechanism through which dysphonia or other throat symptoms develop is unknown but appears to be mediated by a systemic steroid effect.
|
Authors | Atul L Bhat, David W Chow, Michael J DePalma, Cyndi Garvan, Larry Chou, David Lenrow, Curtis W Slipman |
Journal | Archives of physical medicine and rehabilitation
(Arch Phys Med Rehabil)
Vol. 86
Issue 7
Pg. 1330-2
(Jul 2005)
ISSN: 0003-9993 [Print] United States |
PMID | 16003659
(Publication Type: Journal Article)
|
Chemical References |
- Anesthetics, Local
- Drug Combinations
- Glucocorticoids
- Betamethasone
- Lidocaine
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Anesthetics, Local
- Betamethasone
(therapeutic use)
- Drug Combinations
- Female
- Fluoroscopy
- Glucocorticoids
(therapeutic use)
- Humans
- Incidence
- Injections, Spinal
- Lidocaine
- Male
- Middle Aged
- Prospective Studies
- Surveys and Questionnaires
- Time Factors
- Voice Disorders
(chemically induced)
|